suspension for injection
general Nateglinide should not be use in monotherapy .
the pharmacokinetics of insulin product be therefore affect by significant intra- and inter-individual variation .
after 2 hour , check the injection site for redness , swell , or tenderness .
what Levitra be and what it be use for 2 .
content by weight , by volume or by unit
do not store them in or too near the freezer section or cool element .
what KOGENATE Bayer 2000 IU look like and content of the pack
Tablet .
Excipients : contains lactose .
CYP3A4-inducing agent such a phenytoin , carbamazepine , and phenobarbitone .
4 .
137.5 mg
Hertford Road , Hoddesdon Hertfordshire EN11 9BU United Kingdom
in the event of overdose , consider standard measure to remove unabsorbed active substance .
market authorisation holder
the safety and efficacy of ViraferonPeg alone or in combination with ribavirin for the treatment of hepatitis C in liver or other organ transplant recipient have not be study .
Retacrit must not be mix with other medicinal product ( see section 6.2 ) .
antagonism may be observe with nitrofurantoin .
skin and subcutaneous tissue disorder
Jean-Michel ALEXANDRE 7 Gianmartino BENZI Mary TEELING 8
this be because blood contains iron and your body do not have a natural way to remove the excess iron you get with your blood transfusion .
if you take more & # 91 ; Neurontin and associate name & # 93 ; than you should call your doctor or go to the near hospital emergency unit immediately .
1 326 4 010 1 037 291
50-100 Holmers farm Way High Wycombe Buckinghamshire HP12 4EG United Kingdom Tel : + 44 1 494 567 567
in the study of PI-experienced patient , PRO30017 ( amprenavir 600 mg / ritonavir 100 mg twice daily in sub-study A and B with 80 and 37 patient respectively ) , the following mutation emerge in patient with virological failure :
serious birth defect have be see in unborn animal and in the baby of woman treat with efavirenz during pregnancy .
5 .
patient should be give an antihistamine and a painkiller before each infusion .
Efficib
Irish
if their symptom be the same a yours .
in cattle , meloxicam be also a major excretion product in milk and bile whereas urine contain only trace of the parent compound .
do NOT administer – data be unavailable for dose
- your insulin pen do not work properly ,
opaque , white , high density polyethylene ( HDPE ) plastic , 160 ml bottle contain 60 tablet , fit with polypropylene ( PP ) child resistant closure .
it can be take with or without food .
- a family history of osteoporosis
medicinal product use in the treatment of ITP in combination with romiplostim in clinical study include corticosteroid , danazol , and / or azathioprine , intravenous immunoglobulin ( IVIG ) , and anti-D immunoglobulin .
no specific antidote be available .
pandemic influenza vaccine ( whole virion , inactivate , adjuvanted )
due to the know vagotonic effect of cholinesterase inhibitor on heart rate , bradycardia and / or syncope may also occur .
5 212 220 2 423 500 2 353 000 480 000 1 593 000
Dompé Biotec S. P . a .
this be to be expect and be not cause for concern .
this summary be last updated in 01-2009 .
clinical result at week 52 clinical and virological efficacy endpoint be evaluate separately in the HBeAg-positive and HBeAg-negative patient population .
by intent-to-treat analysis of both dose group combine ( n = 57 ) , where patient with miss value be consider virologic failure , the proportion of patient
22 – 33 % ) and 79 % ( 90 % CI : 58 – 102 % ) , respectively , when give with a high fat meal relative to when give under fast condition ( see section 4.4 ) .
general classification for supply
Azoospermia , oligospermia4 Amenorrhea
follow closely the instruction for dosage , monitoring ( blood and urine test ) , diet and physical activity ( physical work and exercise ) a discuss with your doctor .
not applicable .
the heart rate-corrected QT interval in duloxetine-treated patient do not differ from that see in placebo-treated patient .
a improvement may not occur during the first few week or more of treatment , patient should be closely monitor until such improvement occurs .
calculate the dose and the number of Xigris vial need .
treatment failure can occur a a consequence of human coagulation factor IX adsorption to the internal surface of some infusion equipment .
Gabapentin should be use in breast-feeding mother only if the benefit clearly outweigh the risk .
2 .
Dose- dependent side effect be likely to occur .
injection site inflammation , injection site reaction * , dizziness , fatigue , rigor , fever , flu-like symptom , asthenia
there have be case of cardiac failure report from the market when pioglitazone be use in combination with insulin or in patient with a history of cardiac failure .
EXP { mm / YYYY } after first opening use immediately within 24 h ( stored 2 – 8 ° C ) .
- your insulin pen do not work properly ,
Sublingual use
commonly ( more than 1 in 100 patient ) , side effect find at the injection site include : bruising , itch .
it be available a capsule ( 250 mg ) , tablet ( 500 mg ) , a powder to be make up into an oral suspension ( 1 g / 5 ml ) and a powder to be make up into a solution for infusion ( drip into a vein ; 500 mg ) .
read the package leaflet before use .
when two type of insulin be mixed , draw the amount of fast-acting insulin first , follow by the amount of long-acting insulin .
in renal insufficiency the tablet should be give only under control condition for hyperphosphataemia .
6 .
-the Committee agree that the efficacy of terfenadine contain medicinal product be consider similar to the other NSAHs .
very rarely ( less than 1 in 10,000 patient ) , difficulty breathing ( bronchospasm ) have be report .
X X
the product can be re-activated up to 48 hour after initial activation and use up to 12 hour after the second activation .
dose adjustment may also be require , for example , if
your doctor will calculate your dose of ADVATE ( in international unit or IU ) depend on your condition and body weight , and on whether it be use for prevention or treatment of bleeding .
at 5 mg / kg / day ( approximately equivalent to human AUC exposure at the 100 mg dose ) , only blister be observe .
Latvija Sanofi Aventis Latvia SIA Vakcīnu nodaļa Tel . : + 371 7103010
Intramuscular use Vial , glass Intramuscular use Vial , glass
s ori 2 .
it may harm them , even if their symptom be the same a yours . • If any of the side effect get serious , or if you notice any side effect not list in this leaflet , please tell your doctor or pharmacist .
remove the cap from the powder vial by gently move it from side to side several time , whilst at the same time pull upwards .
in view of the above , in some clinical situation blood transfusion should be the preferred treatment for the management of anaemia in patient with cancer .
the manufacturing authorisation holder responsible for batch release
in addition , consideration should be give to refer the patient to a paediatric specialist ( see section 5.1 ) .
there be other medicine that may not mix with REYATAZ .
4 .
table 1
active ingredient :
Alprazolam metabolism be inhibit follow the introduction of ritonavir .
0.3 % )
er The haemoglobin should be measure every one or two week until it be stable .
see section 5.1 ( Pharmacodynamics ) .
- 4 vial of powder for solution for injection and 4 ampoule of solvent for parenteral use ;
do not take Stalevo
please make sure to select an appropriate dosage form and strength .
Duloxetine be not genotoxic in a standard battery of test and be not carcinogenic in rat .
CYP2D6 isoenzyme :
EXP { mm / YYYY }
CPMP / 1327 / 03 6.5 Nature and content of container
EU / 1 / 01 / 185 / 033
Sprimeo 300 mg film-coated tablet Aliskiren
7 6.5 Nature and content of container
 EMEA 2002
Agenerase 15 mg / ml oral solution .
( 11-47 ) 0 29 11 ( 6-19 ) 4 ( 2-4 ) 7 ( 3-9 )
reproduction be authorise provide the source be acknowledge . fall .
erythropoietin receptor may be express on the surface of a variety of tumour cell .
if there be evidence of filter clogging , the filter must be replace .
this be because Vidaza may affect the way some other medicine work .
clinical particular
8-11 ) at 10 and 80 mg dos compare to placebo and an increase in QTci of 4 msec ( 90 % CI :
5.1 Pharmacodynamic property
for the active immunisation of red fox and raccoon dog to prevent infection by rabies virus .
one capsule contain 200 mg of saquinavir a saquinavir mesilate .
the Board look at a number of issue during it meeting , focus on a mix of operational and future policy issue .
keep the container in the outer carton in order to protect from light .
Rabigen contains live rabies virus .
name OF the medicinal product AND route ( s ) OF administration
in case of severe haematological reaction , include pancytopenia , Arava and any concomitant myelosuppressive medication must be discontinue and a leflunomide washout procedure initiate .
read all of this leaflet carefully before you start use this medicine .
Portugal GlaxoSmithKline – Produtos Farmacêuticos , Lda Tel : + 351 21 412 95 00 FI.PT @ gsk.com
congenital protein C deficiency
Capsule , hard
Ceftriaxone Tyrol Pharma and associate name ( See Annex I ) 1 g powder for solution for injection or infusion & # 91 ; See Annex I - To be complete nationally & # 93 ;
4 .
breathe difficulty .
information for the user
in this leaflet :
infection During the first 13 week after treatment with Zevalin , patient very commonly developed infection .
AMMONAPS .
a
Degarelix 240 / 80 mg 52 % 96 % 99 % 100 % 100 %
adult - 3 million IU 3 time a week ( every other day ) inject subcutaneously ( under the i dic
Time-points for measurement be 5 min , 1 , 6 , 24 , 96 and 360 hour .
Conjunctivitis .
treatment should be initiate only by a physician experience in the treatment of patient with hepatitis B or C .
Sucrose , mannitol , glacial acetic acid , and sodium hydroxide .
Roche registration limit 6 Falcon Way Shire Park Welwyn garden City AL7 1TW United Kingdom
patient with primary aldosteronism generally will not respond to antihypertensive medicinal product act through inhibition of the renin-angiotensin system .
market authorisation holder and manufacturer
activity profile for NovoMix 70 in healthy Caucasian subject .
2 .
other special warning ( s ) , if necessary
statement OF active substance ( s )
serious hypoglycaemia may cause a heart attack or brain damage and may be life-threatening .
102 particular to appear on the outer packaging
surgery :
effect on tumour growth
3 .
the marketing authorisation holder be Janssen-Cilag International NV .
20 mg
target tissue
powder : glycine disodium hydrogen phosphate heptahydrate sodium dihydrogen phosphate dihydrate
Thalidomide be a poor substrate for cytochrome P450 isoenzymes and therefore clinically important interaction with medicinal product metabolize by this enzyme system be unlikely .
24 There be no specific antidote for olanzapine .
subject incidence Very Common ( ≥ 1 / 10 ) Common ( ≥ 1 / 100 to & lt ; 1 / 10 )
read enclose package LEAFLET
overdose
Hyponatremia may be due to a syndrome of inappropriate anti-diuretic hormone secretion ( SIADH ) .
similar side effect be see in adult and in child .
0.7 ml ( 100 µg / 0.5 ml )
Valsartan be primarily eliminate in faeces ( about 83 % of dose ) and urine ( about 13 % of dose ) , mainly a unchanged drug .
this regress during the course of continued therapy .
do not chew the tablet because they do not taste nice . b .
Sverige E .
4.0 % )
pharmacological property
Rheumatoid arthritis
you should use ARICLAIM only after discuss the potential benefit and any potential risk to your unborn child with your doctor .
the effect of CYP2C9 inducer such a rifampicin on the pharmacokinetic of irbesartan have not be evaluate .
2 .
these reaction resolve over an average of 4 day .
treatment should be discontinue in case of :
- glucagon ( pancreas hormone use to treat severe hypoglycaemia ) ,
pure red cell aplasia
L04AD02
recommendation concern
6.6 Special precaution for disposal
pharmaceutical form
14 .
4.2 Posology and method of administration
seizure , peripheral neuropathy
Germany
Gastrointestinal symptom such a nausea , vomit , diarrhoea , abdominal pain occur most frequently during initiation of therapy and resolve spontaneously in b
outer box
Nitisinone have show embryo-foetal toxicity in the mouse and rabbit at clinically relevant dose level .
seizure where in most case a history of seizure or risk factor for seizure be report Neuroleptic malignant syndrome ( see section 4.4 ) Dystonia ( include oculogyration ) Tardive dyskinesia discontinuation symptoms7
Insulin Human Winthrop Rapid be use to reduce high blood sugar in patient with diabetes mellitus .
1 .
suspension for injection
cardiovascular monitoring be necessary to detect possible arrhythmia .
n / a
- inactive ingredient in the blue , immediate-release layer : maize starch , microcrystalline
remove the carton of Myocet constituent from the refrigerator .
very common : if you suffer from high blood pressure and type 2 diabetes with kidney disease , blood test may show an increased level of potassium .
a with other interferon , caution should be exercise when administer Pegasys in combination with other potentially myelosuppressive agent .
12 .
in addition , the selection of L74V and K65R be reduce when co-administered with ZDV ( K65R : without ZDV :
0.3 ml ( 100 µg / ml )
( -15 , + 4 ) ( -13 , + 6 )
therefore , concomitant use of aliskiren and P-gp potent inhibitor be contraindicate ( see section 4.3 ) .
special precaution for disposal OF unused medicinal product or waste material derive from such medicinal product , if appropriate
if you have be tell by your doctor that you have an intolerance to some sugar , contact your doctor before take this medicinal product .
dose reduction of methadone may be need ( see section 4.5 ) .
for pediatric patient 1-18 year of age , clinical data in paediatric patient have demonstrate that a
Micturition frequency , urinary incontinence
mechanism of action : it be expect to block all action of angiotensin-II mediate by the AT1 receptor , regardless of the source or route of synthesis of angiotensin-II .
if this occur , active supportive therapy should be start immediately .
EMEA / V / C / 054 EMEA / CVMP / 417488 / 2006
general disorder and administration site condition
general disorder and Administration site Conditions fatigue ( 10.9 % )
in addition , an updated RMP should be submit :
0.088 mg
you should check with your doctor or pharmacist if you be not sure .
there be no data on the use of Prepandrix give at the same time a other vaccine .
Olanzapine be start at 2.5 mg / day and titrate to a maximum of 15 mg / day base on investigator judgement .
Inflammation of the liver have also be report .
this be do by slow drop-
however the terminal half-life be not significantly alter .
6.2 incompatibility
start dos be increase gradually , after an interval of 3 to 7 day , until the most effective dose be reach .
INTANZA 15 microgram / strain , suspension for injection Influenza vaccine ( split virion , inactivate ) .
In-use cartridge Cartridge in-use ( in the insulin pen ) or carry a a spare may be store for a maximum of 4 week not above 25 ° C away from direct heat ( for example next to a heating unit ) or direct light ( direct sunlight or next to a lamp ) .
• condition or restriction with regard to the safe AND effective use OF the medicinal product
Suomi / Finland Oy GE healthcare Bio-Sciences Ab Kuortaneenkatu 2 FIN-00510 Helsinki Puh / Tel : + 358 10 39411
Oedema
Trazec 120 mg
282 For any information about this medicinal product , please contact the local representative of the Marketing authorisation holder :
onset of action be within ½ hour , reach a maximum effect within 2-8 hour and the entire duration of action be up to 24 hour .
date of first authorisation :
4 .
what benefit have Opgenra show during the study ?
subject be to receive Rapamune ( sirolimus target concentration of 5 to 15 ng / mL ) in combination with a calcineurin inhibitor and corticosteroid or to receive calcineurin-inhibitor-based immunosuppression without Rapamune .
oral use
special precaution for the disposal OF unused product or waste material , if any
Median duration of treatment on dasatinib be 3.5 month with 12 % of patient treat for & gt ; 24 month to date .
COLD-FORMED aluminium BLISTER STRIPS
Reconstitute and dilute before use – see leaflet .
store in a refrigerator .
carefully peel off the backing .
peak plasma nevirapine concentration of 2 ± 0.4 µg / ml ( 7.5 µM ) be attain by 4 hour follow a single 200 mg dose .
general classification for supply
Schering Plough A / s ( Denmark )
these autologous PBPCs may be harvest and infuse after high-dose cytotoxic therapy , either in place of or in addition to bone marrow transplantation .
special warning that the medicinal product must be store out OF the reach AND sight OF child
23 effect ( decrease tissue perfusion due to increase blood viscosity ) .
in animal , adverse effect of azacitidine on male fertility have be document ( see section 5.3 ) .
confirm by another liver test ; if confirm , stop treatment and monitor aminotransferase level at least every 2 week until level have normalise .
6.4 Special precaution for storage
statement OF active substance ( s )
it be not know whether entecavir , the active ingredient in Baraclude , be excrete in human breast milk .
duration of therapy ( day )
Solvent :
Enbrel 50 mg solution for injection in pre-filled syringe Etanercept
limited historical data indicate that treatment for 48 week might be associate with a high sustained response rate ( 11 / 11 ) and with a low risk of relapse ( 0 / 11 a compare to 7 / 96 follow 24 week of treatment ) .
statement OF active substance ( s )
1 vial
• 86 day
7 Portugal
3 .
the primary amino acid sequence be identical to that of natural human FSH .
your doctor will instruct you how to switch from the previous treatment to Karvezide .
5 .
check with your doctor immediately if any of the following side effect occur : chest pain ; change in the way your heart beat ; breathe problem ( include shortness of breath ) , confusion ; feeling depress , want to harm yourself , hallucination , numbness or tingle feeling ; dizziness , convulsion ( & quot ; fit & quot ; ) ; trouble sleeping , think or concentrate ; difficulty remain alert , severe stomach pain or cramp ;
the degree of enhancement be relate to the metabolic pathway of the co-administered protease inhibitor and the impact of the co-administered protease inhibitor on the metabolism of ritonavir .
do not use in animal suffer from impaired hepatic , cardiac or renal function and haemorrhagic disorder , or where there be evidence of ulcerogenic gastrointestinal lesion .
the usual adult dose of REYATAZ capsule be 300 mg once daily with 100 mg ritonavir once daily and with food , in combination with other anti-HIV medicine .
suspension for injection 1 X 3 ml 5 X 3 ml 10 X 3 ml
study 020 show similar activity in NRTI-experienced patient over 24 week .
patient who have a know sensitivity to latex should be advise to avoid touch the inner shield . rod
Pharmachemie B. V .
the sign and symptom of low blood sugar may include headache , drowsiness , weakness , dizziness , confusion , irritability , hunger , fast heartbeat , sweating , and feel jittery .
• • • • •
14 / 33 particular to appear on the outer package
Novartis pharmaceutical UK Ltd .
skin and subcutaneous tissue disorder
accidental ingestion of nitisinone by individual eat normal diet not restrict in tyrosine and phenylalanine will result in elevated tyrosine level .
5.3 Preclinical safety data
the final study report will be provide to the CHMP upon completion .
Lantus 100 unit / ml solution for injection in a cartridge Insulin glargine
Subcutaneous and intramuscular use
manufacture authorisation holder responsible for batch release
26 Annex II
Hypersensitivity to sulphonamides ( see section 4.4 ) .
these adverse reaction occur more commonly in woman .
28 day up to 3 month
within each frequency grouping , undesirable effect be present in order of decrease seriousness .
Sensation of warmth , pain , paraesthesia and rash at the site of application be also commonly observe .
information in BRAILLE
the injection be give to you by a doctor or nurse , usually in a hospital or clinic , such a after an operation .
5 .
Spain
expiry date
administration of the first dose of Pradaxa should occur a minimum of two hour after the catheter be remove .
do not remove the adapter from the plastic housing .
the combination of these substance have an additive antihypertensive effect , reduce blood pressure to a great degree than either component alone .
in this leaflet :
blood and the lymphatic system disorder Uncommon : anaemia not know : severe neutropenia ( see section 4.4 )
in a pre- and postnatal development study limit change in immune function be observe at 11-fold a human 10 mg / kg dose base on AUC ( see section 5.3 ) .
however the terminal half-life be not significantly alter .
overall 6 out of 60 ( 10 % ) with a titer above 10 BU and 3 out of 60 ( 5 % ) with a titer below 10 BU .
Tél / Tel : + 32 2 656 21 11
Lactation :
Temodal 180 mg hard capsule Temozolomide
uncontrolled hypertension .
Diaphragmatic hernia be also see in a peri-post natal toxicity study in rat , which include exposure during the organogenetic period .
dose of iloprost at
Herpes viral infection ( herpes simplex dermatitis & # 91 ; eczema herpeticum & # 93 ; , herpes simplex & # 91 ; cold sore & # 93 ; , Kaposi ’ s varicelliform eruption )
infusion reaction decrease to 2 % follow the second infusion in both rituximab and placebo group .
number of tablet
18 / 33 particular to appear on the outer package
take special care with Infanrix hexa :
system organ Class
how to use Insulin Human Winthrop Rapid 4 .
Chidren and adolescent :
13-02-2006 al
Shelf-life after first open the container :
Kepivance should only be use in adult over the age of 18 year .
thus , when initiate telithromycin in patient already receive any of thesis i
possible side effect 5 .
− hormonal contraceptive contain ethinyl oestradiol a Norvir may reduce the effectiveness of these medicine .
d e 11 .
there be no data in child or adolescent with a history of cardiac disease .
mm / YYYY
the symptom worsen with continued treatment and may be life-threatening if treatment be continue .
Telzir be not recommend for use a monotherapy , due to the rapid emergence of resistant virus .
evaluation of pharmacokinetic property be not require for vaccine .
infrequent , low titre antibody response have be detect in Soliris treat patient across all PNH and non-PNH study with a frequency ( 3.4 % ) similar to that of placebo ( 4.8 % ) .
expiry date
labelling AND packaging LEAFLET
minor include tooth extraction .
the exposed portion of the rubber stopper of the vial be clean with alcohol ( 70 % ) prior to insertion of the needle .
if cytopenia be unrelated to leukaemia , reduce dose of Glivec to 400 mg .
appropriate therapy such a blood transfusion may be give to patient when indicate .
dysgeusia hypoaesthesia
Chromosome abnormality
in healthy volunteer after intravenous administration , interferon beta-1a exhibit a sharp multi-exponential decline , with serum level proportional to the dose .
- severe allergic reaction ( anaphylactic reaction or anaphylactic shock , which can be fatal -
name AND address OF the marketing authorisation holder
1 .
what Targretin be and what it be use for 2 .
↑ 37 %
► In insulin infusion pump ► If FlexPen be drop , damage or crush , there be a risk of leakage of insulin ► If it hasn ’ t be store correctly or if it have be frozen ( see 6 How to store Levemir ) ► If the insulin do not appear water clear and colourless .
tenofovir disoproxil fumarate and didanosine be not recommended ( see section 4.4 ) .
an overdose of cysteamine may cause progressive lethargy .
the cycle be repeat every 3 week for 3 cycle .
like a number of other quinolones , ciprofloxacin be phototoxic in animal at clinically relevant exposure level .
method AND route ( s ) OF administration
renal impairment : although no dose adjustment be consider necessary for amprenavir , Agenerase oral solution be contraindicate in patient with renal failure ( see section 4.3 ) .
marketing authorisation number ( s )
1 .
C ) 154 d ays d ) 363 day
4 caution be advise when Agenerase be use concomitantly with delavirdine ( see section 4.5 ) .
abnormal dream , insomnia confusion , hallucination , libido disorder abnormal behaviour , delusion , hypersexuality , increase eating , paranoia , pathological gambling
expiry date
instruction on use
injection into a muscle ( intramuscular ) should only be give by a doctor or a nurse .
not know Metabolism and nutrition disorder
name OF the medicinal product
14 6.6 Special precaution for disposal and other handling
pet study in human and preclinical data suggest that TMZ cross the blood-brain barrier rapidly and be present in the CSF .
you should always consider the possibility of a technical problem if , in order to achieve the desired blood sugar level ,
granule for oral suspension
Zalasta 10 mg tablet
the exposure-adjusted rate be 0.06 event per 100 patient-years .
0.5
special precaution to be take by the person administer the veterinary medicinal product to animal
Italia GlaxoSmithKline S. P . a .
these measure will help to protect the environment .
in child , symptom of accidental overdose include ataxia , dizziness , vomit , rash , diarrhea , tremor , and flushing , and elevation in alkaline phosphatase .
if the NeuroBloc solution be not clear and colourless / light yellow or if the vial appear damage the product should be discard a Medical Biohazardous Waste in accordance with local requirement .
special precaution for disposal OF unused medicinal product or waste material derive from such medicinal product , if appropriate
number of white blood cell ( leucopenia ) ; decrease in the number of all blood cell ( pancytopenia ) ,
that be compatible for use with SoloStar should be use .
in Finland the product have be authorise for the indication : “ The treatment of fever and inflammation in cattle ” .
Česká republika MEDA Pharma s.r.o .
the final report will be submit upon completion .
the food- interaction study be not perform accord to the CHMP guideline .
15 .
can then be fit into the neck of the bottle and press firmly down .
Zeffix can be take with food or on an empty stomach .
concomitant use of sildenafil with ritonavir dose a an antiretroviral agent or a a pharmacokinetic enhancer be not recommended and in no instance should sildenafil dos exceed 25 mg in 48 hour ( see also section 4.4 ) .
the diluted solution must be clear and colourless .
the mean platelet count nadir measure be approximately 40 % of baseline .
Roche registration Ltd .
no clinical benefit could be demonstrate in patient with KPS ≤ 80 who be 65 year of age or old .
qualitative AND quantitative composition
pharmacological property
Plasma protein binding of irbesartan be approximately 96 % , with negligible bind to cellular blood component .
1 tablet MIRAPEXIN 1.1 mg three time a day
d ZIMULTI be available in blister pack of 14 , 28 , 30 , 56 , 84 , 90 and 98 tablet , in perforated unit dose
EU / 1 / 05 / 323 / 008
request for general information pack should be send to
method AND route ( s ) OF administration
Dyspnoea ( G3 / 4 :
for the full list of all side effect report with Erbitux , see the Package Leaflet .
general disorder and administration site condition Uncommon - injection site reaction injection site reaction ( redness , swell , itch , pain and haematoma at the injection site ) may occur during treatment with insulin .
at such time , it may be necessary to discontinue oral hypoglycaemic treatment and replace it with insulin on a temporary basis .
do not take Clopidogrel Winthrop :
2 mg / ml
15 2
the first symptom come on slowly over many hour or day .
